Axi-cel more effective but tisa-cel less toxic in large B-cell lymphoma ExpertDr Emmanuel Bachy, Hospices Civils de Lyon, France TrialJULIET, ZUMA-1 ConferenceASH 2021 4 February, 2022 10:15
Infectious complications mild and not common in patients receiving CAR-T therapy for diffuse large B cell lymphoma Presented ByDr Roberta Di Blasi, Hospital Saint-Louis, France TrialJULIET and ZUMA1 ConferenceEHA 2019 9 August, 2019 19:55